Literature DB >> 10558955

Chloroquine resistance in Plasmodium falciparum and polymorphism of the CG2 gene.

L K Basco1, P Ringwald.   

Abstract

A distinct genotype (designated Dd2-type profile) consisting of 12 point mutations and 3 repetitive regions of the CG2 gene, a candidate gene for chloroquine resistance, has been associated with in vitro resistance in laboratory-adapted strains of Plasmodium falciparum. The DNA sequence of clinical isolates, characterized by in vitro and in vivo tests, was analyzed to evaluate whether the genotype corresponds to the phenotype in naturally occurring parasites. Eight of 11 chloroquine-resistant isolates had the Dd2 genotype. One resistant isolate (by in vitro assay) with a sensitive CG2 genotype was sensitive in vivo. Two resistant isolates and 6 sensitive isolates were multiple infections with mixed alleles. No typical CG2 genotype was found corresponding to the chloroquine-sensitive isolates. These results suggest a strong association between the drug-resistant and CG2 genotypes and support the hypothesis that the CG2 gene may be implicated in chloroquine resistance.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10558955     DOI: 10.1086/315150

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  3 in total

1.  Malaria parasite genome scan: insights into antimalarial resistance.

Authors:  Bhavna Gupta; Gauri Awasthi; Aparup Das
Journal:  Parasitol Res       Date:  2010-05-25       Impact factor: 2.289

2.  Lack of association between putative transporter gene polymorphisms in Plasmodium falciparum and chloroquine resistance in imported malaria isolates from Africa.

Authors:  Sandrine Cojean; Alain Noël; Dimitri Garnier; Véronique Hubert; Jacques Le Bras; Rémy Durand
Journal:  Malar J       Date:  2006-03-28       Impact factor: 2.979

Review 3.  Genetics of chloroquine-resistant malaria: a haplotypic view.

Authors:  Gauri Awasthi; Aparup Das
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-12       Impact factor: 2.743

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.